Each day that policymakers decide not to take on health interests is a day that those interests get bigger and tougher to dislodge.
Big Pharma
Posted inTAP
The Vaccine Waiver Invites Reform of Intellectual-Property Abuses
Today on TAP: The patent system no longer works to promote and reward invention
Posted inCoronavirus
Will Biden Favor Drug Companies—or Billions of People Needing COVID Vaccines?
As the global humanitarian crisis deepens, so far the U.S. government is siding with Big Pharma.
Posted inMoney, Politics, and Power
Place Human Lives Over Pharma’s Property Rights
The Biden administration is divided over whether to waive trade protections for Big Pharma—with Commerce Secretary Gina Raimondo as a key industry ally.
Posted inPolitics
The Progressive Policies Moderates Hate Provide the Cost Savings Moderates Claim to Want
If moderate Democrats are serious about their demands to offset the cost of Biden’s infrastructure plan, they can start by saving billions through prescription drug price reform.
Posted inLaw and Justice
The Sackler Family’s Bankruptcy Scheme
Even though they have billions to spare, the Sacklers want a bankruptcy judge to let them off the hook for personal liability in the OxyContin scandal.
Posted inMoney, Politics, and Power
Toward a Conflict-of-Interest-Free West Wing
Incomplete disclosures from Biden’s staff raise as many questions as they answer.
Posted inMoney, Politics, and Power
Astroturf Campaign Attacks Discount Drug Program for the Poor
An anti–government waste group is helping its Big Pharma funder oppose a discount drug program that doesn’t cost the government a penny.
Posted inCoronavirus
A Shot in the Arm
How government succeeded in coronavirus vaccine development, and failed in distribution
Posted inTAP
COVID Vaccines: The Deep State Wins One
Today on TAP: The FDA will not grant early approvals